RED PHARMA LABORATORIES POLSKA SPÓŁKA AKCYJNA
UL. SŁONECZNA 116A, 05-500 STARA IWICZNA
TAX ID1132868960
Rate company:
RED PHARMA LABORATORIES POLSKA SPÓŁKA AKCYJNA
TAX ID1132868960
KRS0000688246
Share capital580,000.00 zł
address
UL. SŁONECZNA 116A, 05-500 STARA IWICZNA
Website
https://www.red-pharma.com/Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
1132868960 
REGON
146874154
KRS
0000688246
Legal form
joint stock company
Register Address
UL. SŁONECZNA 116A, 05-500 STARA IWICZNA
Date of registration in KRS
2017-08-10
Date of commencement of economic activity
2017-08-10
Act signature
RDF/563575/23/223
Website
HTTPS://WWW.RED-PHARMA.COM/
Pkd codes
20.42.Z - Manufacture of perfumes and toilet preparations
10.86.Z - Manufacture of homogenised food preparations and dietetic food
20.41.Z - Manufacture of soap and detergents, cleaning and polishing preparations
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
46.45.Z - Wholesale of perfume and cosmetics
46.46.Z - Wholesale of pharmaceutical goods
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
47.75.Z - Retail sale of cosmetic and toilet articles in specialised stores
Payer VAT status
Active
Vat list bank account(s)
PL90 1090 1694 0000 0001 3465 9374 
PL61 1240 6335 1111 0010 5374 6635 EU grants
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale  | 0,1 | -0,1 | 0 | 171,7 |
Gross profit (loss) | 0 | -0 | 0,1 | 974,1 |
EBITDA | 0,3 | 0,2 | 0,3 | 46,4 |
Short time liabilities | 0,8 | 0,8 | 0,9 | 12,9 |
Other operating costs | 0,2 | 0,1 | 0,2 | 88,8 |
Equity capital | 0,5 | 0,5 | 0,6 | 11,8 |
Operating profit (EBIT) | 0,1 | 0,1 | 0,1 | 159,8 |
Assets | 1,8 | 1,8 | 2,4 | 34,1 |
Net profit (loss) | 0 | -0 | 0,1 | 847,6 |
Cash | 0,3 | 0,1 | 0 | -64,8 |
Liabilities and provisions for liabilities | 1,2 | 1,2 | 1,8 | 43,7 |
Net income from sale | 4 | 4,1 | 4,9 | 20 |
Working assets | 1,2 | 1,3 | 1,4 | 6,6 |
Other income costs | 0,2 | 0,2 | 0,3 | 34,5 |
Depreciation | 0,2 | 0,1 | 0,1 | -6,6 |
% | % | % | p.p. | |
Profitability of capital | 4,2 | -1,8 | 11,9 | 13,7 |
Equity capital to total assets | 31,1 | 30,2 | 25,2 | -5 |
Gross profit margin | 0,6 | -0,2 | 1,7 | 1,9 |
EBITDA Margin | 7,6 | 4,2 | 5,1 | 0,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 76 | 73 | 69 | -4 |
Current financial liquidity indicator | 1.4247206449508667 | 1.584195613861084 | 1.496523380279541 | -0,1 |
Net dept to EBITDA | 0.5265529751777649 | 2.2419474124908447 | 3.221264362335205 | 1 |
Financial statements
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.